Home  »  Hot Stocks   »  We Analyzed the Future Direction of Ra Medical Sys...

We Analyzed the Future Direction of Ra Medical Systems Inc. (RMED), Here is What We Found

Ra Medical Systems Inc. (AMEX:RMED) went up by 8.30% from its latest closing price compared to the recent 1-year high of $140.00. The company’s stock price has collected -12.24% of loss in the last five trading sessions.

Is It Worth Investing in Ra Medical Systems Inc. (AMEX :RMED) Right Now?

Plus, the 36-month beta value for RMED is at 0.87.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

RMED currently public float of 1.08M and currently shorts hold a 23.13% ratio of that float. Today, the average trading volume of RMED was 755.15K shares.

RMED’s Market Performance

RMED stocks went down by -12.24% for the week, with a monthly drop of -44.79% and a quarterly performance of -67.16%, while its annual performance rate touched -97.90%. The volatility ratio for the week stands at 10.48% while the volatility levels for the past 30 days are set at 10.66% for Ra Medical Systems Inc. The simple moving average for the period of the last 20 days is -23.11% for RMED stocks with a simple moving average of -80.33% for the last 200 days.

Analysts’ Opinion of RMED

Many brokerage firms have already submitted their reports for RMED stocks, with Piper Jaffray repeating the rating for RMED by listing it as a “Neutral.” The predicted price for RMED in the upcoming period, according to Piper Jaffray is $1.50 based on the research report published on August 13th of the previous year 2019.

Maxim Group, on the other hand, stated in their research note that they expect to see RMED reach a price target of $23. The rating they have provided for RMED stocks is “Buy” according to the report published on November 02nd, 2018.

RMED Trading at -49.37% from the 50-Day Moving Average

After a stumble in the market that brought RMED to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.18% of loss for the given period.

Volatility was left at 10.66%, however, over the last 30 days, the volatility rate increased by 10.48%, as shares sank -44.07% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -68.19% lower at present.

During the last 5 trading sessions, RMED fell by -12.24%, which changed the moving average for the period of 200-days by -86.30% in comparison to the 20-day moving average, which settled at $3.21. In addition, Ra Medical Systems Inc. saw -96.74% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for RMED

Current profitability levels for the company are sitting at:

  • -133027.27 for the present operating margin
  • -6990.91 for the gross margin

The net margin for Ra Medical Systems Inc. stands at -123913.64.

The liquidity ratio also appears to be rather interesting for investors as it stands at 3.17.

Is Twilio Inc. (TWLO) a Keeper?

Twilio Inc. (NYSE:TWLO) went down by -5.24% from its latest closing price compared to the recent 1-year high of $289.00. The company’s stock price has

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]